We anticipate Coles and Woolworths to report food price deflation continued in the September quarter of 2021. However, we expect prices to reflate in the December quarter with food inflation to average 1.5% in fiscal 2022. We forecast higher prices to support the operating margins of supermarket operators, offsetting weak sales growth post-lockdowns.
Morningstar’s proprietary Little Shopping Basket indicates prices were flat at Coles and declined by 1% at Woolworths in the September quarter 2021 versus the prior corresponding period against a backdrop of rising upstream costs, including cost pressures experienced by manufacturers of consumer-packaged goods, or CPGs.
Heading into the upcoming release of first-quarter fiscal 2022 sales figures in late October, we maintain our fair value estimates of AUD 24.00 and AUD 13.20 per share for narrow moat Woolworths and no-moat Coles, respectively.
Although we estimate Woolworths dropped prices by more than Coles in the September quarter, our shopping basket was still cheaper at Coles than at Woolworths. Our average Coles basket was priced at a 2% discount to the average Woolworths basket consisting of identical items, suggesting Coles competed more aggressively on price.
Large global suppliers have been sounding the alarm regarding inflationary pressures within their supply chains.
Nonetheless, we don’t anticipate rising input costs to materially impact profit margins at Coles and Woolworth in fiscal 2022, as their suppliers are likely to partially internalise any inflation, and we expect the supermarkets to successfully pass on higher cost of goods sold to consumers in the form of low-single-digit price rises. Coles and Woolworths enjoy dominating positions within the Australian grocery retailing sector and can leverage buying power in their price negotiations with suppliers. Increasing the level of private label penetration also offers supermarkets the option to better manage the price of their baskets.
From fiscal 2024, we expect sales growth of the Australian food retailing industry to recover to a sustainable rate of about 4% annually, underpinned by food price inflation of 2.5% and population growth of around 1.5%.
We also track a discount grocery basket, comparing private label product pricing at Woolworths, Coles, and Aldi. Our discount basket indicates prices were roughly the same at Woolworths and Aldi in the September quarter 2021, while the average private label product at Coles was priced at around a mid-single-digit premium, after adjusting for packaging sizes.
We infer from our baskets differences in pricing strategies between the two majors. We conclude Woolworths aims to match Aldi on private label pricing, while Coles’ comparable private label range is less competitively priced. Rather, Coles seems to be focusing on matching Woolworths on its branded product range.
However, we caution the readthrough from our baskets has its limitations due their small sample sizes. Morningstar’s Little Shopping Basket and our discount grocery basket each track only a small subset of products across the vast ranges stocked by Australian supermarket retailers. Also, over time periods shorter than a full year promotional cycle, differences in promotional schedules impact results.
(Source: Morningstar)
General Advice Warning
Any advice/ information provided is general in nature only and does not take into account the personal financial situation, objectives or needs of any particular person.
Between data processing units, or DPUs, optical interconnect, and ethernet solutions, Marvell has one of the broadest networking silicon portfolios in the world, and we think it is primed to steal market share from incumbent Broadcom with bleeding-edge technology.
Marvell has exited its low-margin legacy markets of consumer hard disk drives and Wi-Fi chipsets to focus on its networking portfolio and used the acquisitions of Cavium, Avera, Aquantia, Inphi, and Innovium to expand out of its enterprise market niche into the rapidly growing data center and 5G markets.
Marvell’s recent financial history has been choppy as a result of CEO Matt Murphy’s aggressive overhaul of the business’ focus. Trends toward disaggregated networks and merchant silicon, as well as 5G and data center buildouts, would act as secular tailwinds for Marvell.
Financial Strength:
As of May 1, 2021, the firm carried $522 million in cash and $4.7 billion in total debt—largely taken on to acquire Inphi. Marvell is expected to exit fiscal 2022 with a gross debt/adjusted EBITDA ratio of 2.4 times, above its target of 2 times. As per the analysts, Marvell is expected to stay leveraged but to pay down debt as it matures.
The firm’s free cash flow generation is expected to ramp up toward $2 billion a year by fiscal 2026, up from just over $700 million in fiscal 2021, as it exacts material operating leverage with top-line growth.
The firm would be prudent to postpone any M&A until it returns below its debt/EBITDA target, following $11 billion spent so far in fiscal 2022 on Inphi and Innovium.
Bulls Say:
- Marvell has best-of-breed data processing units and optical interconnect products that should allow it to benefit from the rapidly growing cloud and 5G markets.
- We think the combination of Inphi and Innovium under the Marvell umbrella could give it a technological advantage to Broadcom in high-performance networking.
- We expect Marvell to exact significant operating leverage as it incorporates acquisitions and adds volume to the top line.
Company Profile:
Marvell Technology is a leading fabless chipmaker focused on networking and storage applications. Marvell serves the data center, carrier, enterprise, automotive, and consumer end markets with processors, optical
interconnections, application-specific integrated circuits (ASICs), and merchant silicon for ethernet applications. The firm is an active acquirer, with five large acquisitions since 2017 helping it pivot out of legacy consumer applications to focus on the cloud and 5G markets.
(Source: Morningstar)
General Advice Warning
Any advice/ information provided is general in nature only and does not take into account the personal financial situation, objectives or needs of any particular person.
While dominating the fragmented Australian market, and being a large global player in commodity and environmental testing, it is trumped by the majors, Bureau Veritas, SGS, and Intertek in nondestructive testing and inspection. Services include laboratory testing for the mineral, coal, environmental, food, and pharmaceutical segments.
Excellent reputation, technical capabilities, a global network, and established relationships with global clients are key advantages over often fragmented competitors.ALS’ global network of more than 350 laboratories provides a geographically diverse revenue base: 37% Asia-Pacific, 36% Americas, 24% EMENA, and the balance Africa. This global network reduces region reliance and gives it the capability to leverage experience across borders and serve an international client base.
Financial Strength
ALS is in only reasonable financial health. At the end of fiscal 2015, acquisitions and capital expenditure had pushed net debt to AUD 776 million and gearing (net debt/equity) to 63%. A subsequent AUD 325 million capital raising meant gearing fell to near 40% and net debt/EBITDA from 2.6 times to a manageable 2.0 times. Incremental acquisitions in the life sciences segment’s EBITDA had been accompanied by a sharp rise in group net debt. This has since been paid down to AUD 675 million at end-March 2021. Somewhat elevated leverage (ND/ND+E) of 36% reflects ongoing incremental acquisitions in the life sciences segment, albeit within the limits of ALS’ sub-45% target ratio. Fiscal 2021 net debt/EBITDA of 1.6 is reasonable.
Bulls Say’s
- ALS has diversified the earnings base to mitigate exposure to highly cyclical commodity markets. Expansion into food and pharma testing, as well as inspection and certification markets, should provide growth despite a significant slowdown in minerals testing.
- Large clients are unlikely to move away on price alone, with quality and skills essential requirements.
- Exposure to mineral and coal testing could once again provide earnings growth if the global economy’s appetite for commodities increases.
Company Profile
Founded in the 1880s and listing on the ASX in 1952, ALS operates three divisions: commodities, life sciences, and industrial. ALS commodities traditionally generated the majority of underlying earnings, providing geochemistry, metallurgy, inspection and mine site services for the global mining industry. Expansion into environmental, pharmaceutical and food testing areas and commodity price weakness have lessened earnings exposure to commodities.
General Advice Warning
Any advice/ information provided is general in nature only and does not take into account the personal financial situation, objectives or needs of any particular person.
Investment Thesis:
- U.S. growth opportunity– the U.S. online sports betting market continues to open following the 2018 supreme court ruling which legalise the industry. Market growth estimates forecast the industry to grow to US$51bn by 2033.
- Strong management team with a solid track record – the ability to grow market share in a competitive and mature market of Australia gives us some confidence the management team have the right strategy in place to build share in the U.S.
- Proprietary technology stack – The speed and usability are key differentiating factors. PBH operates proprietary technology, which it developed inhouse. This means new modifications and updates are easier to implement (i.e., more control) with inhouse tech versus outsourced (i.e., having to go to an external provider each time with an update).
- Cross sell opportunities with iGaming – PBH’s recently launched iGaming product (online casino) is already highlighting cross-sell opportunities to its customers.
Key Risks:
- Rising competitive pressures
- Adverse regulatory change in key operating jurisdictions (Australia / U.S.)
- Loss of market share in key regions or growth rate fails to meet market expectations
- Higher than expected costs – especially around investment in sales & marketing to drive market share
- Trading on high PE-multiples / valuations means the Company is more prone to share price volatility
- Cyber-attack on PBH’s platform
Key highlights:
- PBH’s FY21 results were largely in line with expectations, with group revenue up +159% to $194.7m and gross profit up +129% to $87.6m YoY.
- The recently launched iGaming product represents another growth opportunity (backed by a strong management team), with management noting that ~71% of all iGaming players have placed an in-play wager and 40% of cash active clients have placed an iGaming bet since launch.
- The more mature market of Australia still has room to grow, with PointsBet, the no. 5 player (by online market share) and management still targeting 10% online market share by 2025.
- Group normalised EBITDA for the year was a loss of $156.1m vs loss of $37.6m in the pcp, as PBH continues to invest in the business to scale the U.S. business and invests in its technology stack.
- Australian Trading segment reported revenue of $150.7m (vs $68.2m in pcp) and EBITDA of $9.2m (vs $6.9m in the pcp).
- USA segment reported revenue of $42.3m (vs $7.0m in pcp) and EBITDA loss of $149.6m (vs loss of $38.2m in pcp). During the year, PBH operational in six U.S. states: New Jersey, Iowa, Indiana, Illinois, Colorado, and Michigan.
- Balance sheet is in a good position to support investment in growth, with pro forma cash balance of $665.2m (post the July 21 capital raising).
Company Description:
PointsBet Holdings Ltd (PBH), founded in 2015, is a corporate bookmaker with operations in Australia and the United States (New Jersey, Iowa, Illinois and Indiana). PointsBet has developed a scalable cloud-based wagering platform which offers customers sports and racing wagering products. PBH’s key products include fixed odds sports, fixed odds racing and PointsBetting.
General Advice Warning
Any advice/ information provided is general in nature only and does not take into account the personal financial situation, objectives or needs of any particular person.
